- Home
- IMNM vs TRIN Comparison
IMNM vs TRIN Comparison
Compare IMNM & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- TRIN
- Stock Information
- Founded
- IMNM 2006
- TRIN 2007
- Country
- IMNM United States
- TRIN United States
- Employees
- IMNM N/A
- TRIN N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- TRIN Finance/Investors Services
- Sector
- IMNM Health Care
- TRIN Finance
- Exchange
- IMNM Nasdaq
- TRIN Nasdaq
- Market Cap
- IMNM 1.2B
- TRIN 1.2B
- IPO Year
- IMNM 2020
- TRIN 2021
- Fundamental
- Price
- IMNM $16.39
- TRIN $15.22
- Analyst Decision
- IMNM Strong Buy
- TRIN Buy
- Analyst Count
- IMNM 9
- TRIN 4
- Target Price
- IMNM $24.89
- TRIN $15.63
- AVG Volume (30 Days)
- IMNM 1.3M
- TRIN 812.9K
- Earning Date
- IMNM 11-12-2025
- TRIN 11-05-2025
- Dividend Yield
- IMNM N/A
- TRIN 13.40%
- EPS Growth
- IMNM N/A
- TRIN 32.58
- EPS
- IMNM N/A
- TRIN 2.25
- Revenue
- IMNM $12,589,000.00
- TRIN $254,887,000.00
- Revenue This Year
- IMNM N/A
- TRIN $27.19
- Revenue Next Year
- IMNM $85.68
- TRIN $8.97
- P/E Ratio
- IMNM N/A
- TRIN $6.77
- Revenue Growth
- IMNM 16.74
- TRIN 33.44
- 52 Week Low
- IMNM $5.15
- TRIN $12.50
- 52 Week High
- IMNM $17.32
- TRIN $16.82
- Technical
- Relative Strength Index (RSI)
- IMNM 65.16
- TRIN 51.29
- Support Level
- IMNM $15.35
- TRIN $14.72
- Resistance Level
- IMNM $17.21
- TRIN $15.15
- Average True Range (ATR)
- IMNM 1.14
- TRIN 0.28
- MACD
- IMNM -0.01
- TRIN 0.07
- Stochastic Oscillator
- IMNM 75.79
- TRIN 83.67
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.